|
Study on the mechanism of Wikstroemia indica in the treatment of
inflammatory diseases based on network pharmacology
Jiayi Li, Zisong Bai, Tingting Guo, Heng Zhang, Gang Chen, Di Zhou, Ning Li
2021 (1):
10-23.
摘要
(
391 )
PDF(3940KB)
(
417
)
Wiksroemia indica belongs to the family of Thymelaeaceae. As a material of Traditional Chinese Medicine, it is mainly used to
treat inflammation-related diseases. However, due to its complex composition, the scientific basis for its traditional application
is still insufficient and the mechanism of action is still unclear. At present, most studies on its anti-inflammatory effect focus on a
certain component and its different solvent fractions. There are few reports about the synergistic mechanism of the constituents
from W. indica for the treatment of inflammatory diseases. Therefore, the present study aimed to uncover its potential mechanism
from a holistic perspective using the network pharmacology approach. Firstly, compounds in W. indica and genes associated with
inflammatory diseases were obtained. Then, the active compounds were screened out and their targets were predicted. After that,
the key targets for W. indica to treat inflammatory diseases were screened out. Finally, the protein-protein interaction (PPI), Gene
ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of key targets were performed
to further study the mechanism of W. indica in the treatment of inflammatory diseases. The results showed that the active
constituents of W. indica might play an anti-inflammatory role through the key targets CYP19A1 and CYP1B1, which clarified
the primary mechanism for the treatment of inflammatory diseases and provided a scientific basis for further study of this herb.
相关文章 |
计量指标
|